share_log

UBS Maintains Neutral on Calumet Specialty Prods, Raises Price Target to $19.5

Benzinga ·  May 15, 2023 07:36

UBS analyst Manav Gupta maintains Calumet Specialty Prods (NASDAQ:CLMT) with a Neutral and raises the price target from $18.5 to $19.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment